High Retention in Care Among HIV-Infected Patients Entering Care With CD4 Levels >350 cells/μL Under Routine Program Conditions in Uganda
Author(s) -
Jennifer Namusobya,
Fred C. Semitala,
Gideon Amanyire,
Jane Kabami,
Gabriel Chamie,
John Bogere,
Vivek Jain,
Tamara D. Clark,
Edwin D. Charlebois,
Diane V. Havlir,
Moses R. Kamya,
Elvin Geng
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit490
Subject(s) - medicine , human immunodeficiency virus (hiv) , population , residence , antiretroviral therapy , pediatrics , demography , viral load , gerontology , immunology , environmental health , sociology
In Africa, human immunodeficiency virus (HIV)-infected patients who present to care with CD4 levels >350 cells/µL (ie, current antiretroviral treatment thresholds) are often thought to be poorly retained in care, but most estimates do not account for outcomes among patients lost to follow-up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom